Emerging biotechnologies present many challenges for decision makers. The pace of scientific advancement, combined with uncertainties about the trajectory of future research, make it difficult to envisage what effective and proportionate regulatory mechanisms might look like – which allow for research and innovation, protect people and animals, and inspire public trust in research.

Members of the Working Group: Emily Jackson (Chair), Professor of Law, London School of Economics and Political Science (LSE) Law School Zameel Cader, Professor of Neuroscience and Neurology, University of Oxford Joshua Jowitt, Senior Lecturer in Law, University of Newcastle Madeline Lancaster, Group Leader (Cell Biology division), MRC Laboratory of Molecular Biology, University of Cambridge John Suckling, Research Professor in Psychiatric Neuroimaging, University of Cambridge; and Chair of the Cambridge University Research Ethics Committee Juliet Tizzard, Director of External Relations, Parkinsons UK Latha Weston, Member of the Nuffield Council on Bioethics, co-chair of Mind & Brain Advisory Group; Psychiatrist Stephen Wilkinson, Member of the Nuffield Council on Bioethics; Distinguished Professor of Bioethics, Lancaster University.

Nuffield Council on Bioethics 100 St John Street London EC1M 4EH